Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia

Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic... We recently observed that more than one third of pediatric patients who presented with non‐A, non‐B fulminant liver failure (FLF) also developed aplastic anemia (AA) either before or shortly after liver transplantation. Factors involved in the suppression of bone marrow could be the same as those causing hepatic failure. We considered parvovirus B19 a candidate etiologic agent because of the known tropism of B19 for erythroid precursors. Archived liver and serum from six patients undergoing liver transplantation for non‐A, non‐B, non‐C FLF with associated AA were analyzed for the presence of B19 DNA and anti‐B19 serology. An age‐ and gendermatched control group (N = 44) was analyzed in parallel. B19 DNA studies and anti‐B19 serology were performed in a blinded fashion. B19 serologies were performed by antibody capture enzyme‐linked immunosorbent assay (ELISA). B19 DNA was detected after polymerase chain reaction (PCR) amplification of target B19 DNA sequences in liver and serum. Liver tissue showed evidence of B19 DNA in four of six (66%) patients with FLF and associated AA. Two of 4 patients with cryptogenic FLF but without AA had B19 DNA detected in the liver tissue. Of the 34 remaining controls, only 5 (15%) showed evidence of B19 DNA in liver tissue (66% vs. 15%, P = .016). B19 DNA was not detected in any of the test or control sera. This study provides evidence to support the role of parvovirus B19 in the development of FLF and associated AA. (Hepatology 1995; 22:1661‐1665). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Hepatology Wiley

Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia

Download PDF
5 pages
Read Article

Loading next page...
 
/lp/wiley/parvovirus-b19-as-a-possible-causative-agent-of-fulminant-liver-6PSyQBOnSq
Publisher
Wiley
Copyright
Copyright © 1995 American Association for the Study of Liver Diseases
ISSN
0270-9139
eISSN
1527-3350
DOI
10.1002/hep.1840220608
Publisher site
See Article on Publisher Site

Abstract

We recently observed that more than one third of pediatric patients who presented with non‐A, non‐B fulminant liver failure (FLF) also developed aplastic anemia (AA) either before or shortly after liver transplantation. Factors involved in the suppression of bone marrow could be the same as those causing hepatic failure. We considered parvovirus B19 a candidate etiologic agent because of the known tropism of B19 for erythroid precursors. Archived liver and serum from six patients undergoing liver transplantation for non‐A, non‐B, non‐C FLF with associated AA were analyzed for the presence of B19 DNA and anti‐B19 serology. An age‐ and gendermatched control group (N = 44) was analyzed in parallel. B19 DNA studies and anti‐B19 serology were performed in a blinded fashion. B19 serologies were performed by antibody capture enzyme‐linked immunosorbent assay (ELISA). B19 DNA was detected after polymerase chain reaction (PCR) amplification of target B19 DNA sequences in liver and serum. Liver tissue showed evidence of B19 DNA in four of six (66%) patients with FLF and associated AA. Two of 4 patients with cryptogenic FLF but without AA had B19 DNA detected in the liver tissue. Of the 34 remaining controls, only 5 (15%) showed evidence of B19 DNA in liver tissue (66% vs. 15%, P = .016). B19 DNA was not detected in any of the test or control sera. This study provides evidence to support the role of parvovirus B19 in the development of FLF and associated AA. (Hepatology 1995; 22:1661‐1665).

Journal

Hepatology – Wiley

Published: Dec 1, 1995

References

  • Aplastic anemia complicating orthotopic liver transplantation for non‐A, non‐B hepatitis
    Tzakis, Tzakis; Arditi, Arditi; Whitington, Whitington; Yanaga, Yanaga; Esquivel, Esquivel; Andrews, Andrews; Makowka, Makowka
  • Aplastic anemia after liver transplantation for fulminant hepatic failure
    Cattral, Cattral; Langnas, Langnas; Markin, Markin; Antonson, Antonson; Heffron, Heffron; Fox, Fox; Sorrell, Sorrell
  • Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow
    Srivastava, Srivastava; Lu, Lu
  • Parvovirus B19‐specific DNA in bone marrow from B19 arthropathy patients. Evidence for B19 viral persistence
    Foto, Foto; Saag, Saag; Scharosch, Scharosch; Howard, Howard; Naides, Naides
  • Transient liver enzyme abnormalities in acute human parvovirus (HPV) infection (Abstract)
    Naides, Naides
  • Liver dysfunction caused by parvovirus B19 (Letter to editor)
    Tsuda, Tsuda
  • Fetal survival of human parvovirus B19 infection. Spectrum of intrauterine response in a twin pregnancy
    Weiner, Weiner; Naides, Naides
  • A prospective study of androgen and bone marrow transplantation for treatment of severe aplastic anemia
    Camitta, Camitta; Thomas, Thomas; Nathan, Nathan; Gale, Gale; Kopecky, Kopecky; Rappeport, Rappeport; Santos, Santos
  • Human parvovirus B19 infection among hospital staff members after contact with infected patients
    Bell, Bell; Naides, Naides; Stoffman, Stoffman; Hodinka, Hodinka; Plotkin, Plotkin
  • Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two‐year clinical experience
    Naides, Naides; Scharosch, Scharosch; Foto, Foto; Howard, Howard
  • Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis
    Shade, Shade; Blundell, Blundell; Cotmore, Cotmore; Tattersall, Tattersall; Astell, Astell
  • Detection of human parvovirus using a molecularly cloned probe
    Clewley, Clewley
  • Hepatitis C virus not found in fulminant non‐A, non‐B hepatitis
    Wright, Wright; Hsu, Hsu; Donegan, Donegan; Feinstone, Feinstone; Greenberg, Greenberg; Read, Read; Ascher, Ascher
  • Aplastic anemia and viral hepatitis: non‐A, non‐B, non‐C
    Hibbs, Hibbs; Frickhofen, Frickhofen; Rosenfeld, Rosenfeld; Feinstone, Feinstone; Kojima, Kojima; Bacigalupo, Bacigalupo; Locasciulli, Locasciulli
  • Fulminant or subfulminant non‐A, non‐B viral hepatitis: the role of hepatitis C and E viruses
    Liang, Liang; Jeffers, Jeffers; Reddy, Reddy; Silva, Silva; Cheinquer, Cheinquer; Findor, Findor; De Medina, De Medina
  • Hepatitis C virus and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis
    Feray, Feray; Gigou, Gigou; Samuel, Samuel; Reyes, Reyes; Bernuau, Bernuau; Reynes, Reynes; Bismuth, Bismuth
  • Detection of hepatitis “E” but not “C” in sera of patients with fulminant NANB hepatitis (Abstract)
    Sallie, Sallie; Tibbs, Tibbs; Silva, Silva; Sheron, Sheron; Eddelston, Eddelston; Williams, Williams
  • Hepatitis B virus and appaernt fulminant non‐A, non‐B hepatitis
    Wright, Wright; Mamish, Mamish; Combs, Combs; Kim, Kim; Donegan, Donegan; Ferrell, Ferrell; Lake, Lake; Roberts, Roberts
  • Exclusion in liver by polymerace chain reaction of hepatitis B and C viruses in acute liver feilure attributed to sporadic non‐A, non‐B hepatitis
    Fagan, Fagan; Harrison, Harrison
  • Lack of evidence for hepatitis B virus (HBV) infection in fulminant non‐A, non‐B hepatitis
    Laskus, Laskus; Rakela, Rakela; Wiesner, Wiesner; Steers, Steers; Persing, Persing
  • Syncytial giant‐cell hepatitis sporadic hepatitis with distinct pathological features, a severe clinical course, and paramyxoviral features
    Phillips, Phillips; Blendis, Blendis; Poucell, Poucell; Patterson, Patterson; Petric, Petric; Roberts, Roberts; Levy, Levy
  • Human parvovirus B19 infections in United Kingdom 1984‐86
    Anderson, Anderson; Cohen, Cohen
  • Thrombocytopenia induced by human parvovirus B19 infections
    Yoto, Yoto; Kudoh, Kudoh; Suzuki, Suzuki; Katoh, Katoh; Matsunaga, Matsunaga; Chiba, Chiba
  • Experimental parvoviral infection in humans
    Anderson, Anderson; Higgins, Higgins; Davis, Davis; Willman, Willman; Jones, Jones; Kidd, Kidd; Pattison, Pattison
  • Immune response to B19 parvovirus and an antibody defect in persistent viral infection
    Kurtzman, Kurtzman; Cohen, Cohen; Field, Field; Oseas, Oseas; Blaese, Blaese; Young, Young
  • Chronic bone marrow failure due to persistent B19 parvovirus infection
    Kurtzman, Kurtzman; Ozawa, Ozawa; Cohen, Cohen; Hanson, Hanson; Oseas, Oseas; Young, Young
  • Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease
    Graeve, Graeve; de Alarcon, de Alarcon; Naides, Naides
  • Severe anemia due to B19 parvovirus infection in children with acute leukemia in remission
    Rao, Rao; Miller, Miller; Cohen, Cohen
  • Persistent B19 parvovirus infection in human immunodeficiency virus type 1 (HIV‐1): a treatable cause of anemia in AIDS
    Frickhofen, Frickhofen; Abkowitz, Abkowitz; Safford, Safford; Berry, Berry; Antunez de Mayolo, Antunez de Mayolo; Astrow, Astrow; Cohen, Cohen
  • Parvovirus B19 infection in HIV‐1 infected individuals failing or intolerant to Zidovudine (ZDV) therapy
    Naides, Naides; Howard, Howard; Swack, Swack; Stapleton, Stapleton
  • Pure red‐cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy
    Kurtzman, Kurtzman; Frickhofen, Frickhofen; Kimball, Kimball; Jenkins, Jenkins; Nienhuis, Nienhuis; Young, Young
  • Diagnostic assays with monoclonal antibodies for the human serum parvovirus‐like virus (SPLV)
    Cohen, Cohen; Mortimer, Mortimer; Pereira, Pereira

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial